In the FANTOM II study, the Fantom bioresorbable scaffolds (BRS), featuring a novel polymer and reduced strut thickness, demonstrated low 5-year rates of MACE and scaffold thrombosis, and favorable healing patterns at 24 months. These results, along with the modest late lumen loss (LLL) and low rate of binary restenosis observed, suggest the Fantom BRS as a safe and effective alternative to first-generation BRS and DES for patients with stable coronary artery disease and non-complex lesions. @MJLutz
https://t.co/4q1gc8R5F7
#AGIKwebPCI live und (teilweise) in Farbe (und bisschen schwarzweiss)
➡️ComplexNonCulpritPCI⬅️
🗓️07.03.204 I 18:00 CET
🔗 https://t.co/Z8q72pGVwX
#WIRsindAGIK@AGIKinterv
Sharing a discussion point from one of our INOCA International Medical Advisory Board members.
This is also posted for discussion in our Doctors Only INOCA Case Discussion group.
If you would like to join just click on the link to request membership! https://t.co/GotTLWzXi9
We tend not to shout about what we do at INOCA International, we just get on and do it to the best of our ability to benefit INOCA patients everywhere.
Thank you to all our fantastic Twitter supporters who continually help us to improve understanding of INOCA around the world!🙏
Wow! A huge Thank You to all our Twitter friends and supporters! In less than a week, over 1,000 additional views of our video - now over 4,000 views!
Thank you so much for all your help and support!
The more we all raise awareness the more we can help patients - Thank You! 🙏
Ganz im Stillen hat sich im Restaurant Pastis in #Kiel ein Betreiberwechsel vollzogen. Seit August wird das auch als „Wohnzimmer Düsternbrooks“ bezeichnete Lokal von dem Koch Lars Fauk und seinem Schwager Nicolas Wendelken geführt. https://t.co/0AiyHke4ru
But you are also right. The Encore is that one from @revamedicalinc Fantom Encore. Already CE-marked and 95 micron struts. First 5 years results @TCTConference next week.
Final poll results (767 responses). More than two-thirds want to see coronary BRS investigated again. Major comments included need for implantation under IV imaging guidance and their study in adequate RCTs with long-term FU. [Auto-spell error: device is Esprit not Encore]